RE:RE:RE:Time to jump back in?Given what some ofher covid stocks did just on research progress, this one has been a complete dud. The commercial product is being manufactured, there is some actual sales projections and half a dozen NRs have us hovering from $1.70 to $2.10. A newbie looks at just this and starts looking for red flags. It is difficult to shake that off so any upward movement will have to be on actual sales. This one has missed its sweet spot IMO, the dealer gave us two face cards and we still lost the game of 21. Recovery deepends largely on just how much folk are brave enough to average down. Right now I would only consider it on actual sales announcements, none of the other stuff resonates with the market and there seems to be not very much desire to do much beyond press releases. BY beaming with pride, not even a tweet from the CEO and the company. Looks very awkward to me!